4//SEC Filing
MAYLEBEN TIMOTHY M 4
Accession 0001415889-24-025070
CIK 0001267813other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 7:57 AM ET
Size
14.4 KB
Accession
0001415889-24-025070
Insider Transaction Report
Form 4
MAYLEBEN TIMOTHY M
Director
Transactions
- Gift
Common Stock
2024-10-10−4,980→ 13,957 total(indirect: By Trust) - Gift
Common Stock
2024-10-10−1,660→ 10,637 total(indirect: By Trust) - Gift
Common Stock
2024-10-10−1,660→ 12,297 total(indirect: By Trust)
Holdings
- 1,660(indirect: By Trust)
Common Stock
- 1,660(indirect: By Trust)
Common Stock
- 25,837
Common Stock
- 18,937(indirect: By Trust)
Common Stock
- 6,900
Common Stock
Footnotes (6)
- [F1]The reported amount reflects an adjustment to correct a clerical error that previously underreported the Reporting Person's holdings by 1,462 shares of Marinus Pharmaceuticals, Inc. (the "Issuer") common stock. No reportable transactions were omitted from previous filings in connection with the clerical error underlying this correction.
- [F2]The reported amounts reflect an adjustment to correct an administrative error that previously reported that all of the Reporting Person's holdings in Issuer common stock were owned directly by the Reporting Person. Such amounts have been corrected to reflect shares of Issuer common stock held by the Reporting Person directly (i.e., 6,900 shares underlying restricted stock units) and those held by the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 (i.e., 18,937 shares), of which the Reporting Person is the sole trustee.
- [F3]Represents shares of Issuer common stock held by the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16, of which the Reporting Person is the sole trustee.
- [F4]On October 10, 2024, the Reporting Person transferred an aggregate of 4,980 shares of Issuer common stock from the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 to members of the Reporting Person's immediate family who do not share the Reporting Person's household for no consideration.
- [F5]On October 10, 2024, the Reporting Person transferred 1,660 shares of Issuer common stock from the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 to the Ellery A. Mayleben 2017 Trust for no consideration. The Reporting Person is trustee of the trust, and a member of his immediate family is the sole beneficiary of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose
- [F6]On October 10, 2024, the Reporting Person transferred 1,660 shares of Issuer common stock from the Timothy M. Mayleben Revocable Trust U/A/D 9/16/16 to the Kasey D. Evans 2017 Trust for no consideration. The Reporting Person is trustee of the trust, and a member of his immediate family is the sole beneficiary of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
MARINUS PHARMACEUTICALS, INC.
CIK 0001267813
Entity typeother
Related Parties
1- filerCIK 0001242613
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 7:57 AM ET
- Size
- 14.4 KB